CLINICAL EVALUATION OF SULFALENE (2-SULFANILAMIDO-3-METHOXYPYRAZINE).
D000152:Acne Vulgaris; D035843:Biomedical Research; D001769:Blood; D002177:Candidiasis; D003556:Cystitis; D004358:Drug Therapy; D004927:Escherichia coli Infections; D005853:Geriatrics; D011014:Pneumonia; D011512:Proteus Infections; D012141:Respiratory Tract Infections; D013203:Staphylococcal Infections; D013415:Sulfalene; D013449:Sulfonamides; D014552:Urinary Tract Infections; D014556:Urine
D013449:Sulfonamides; D013415:Sulfalene
ACNE; BLOOD; CLINICAL RESEARCH; CYSTITIS; DRUG THERAPY; ESCHERICHIA COLI INFECTIONS; GERIATRICS; MONILIASIS; PNEUMONIA; PROTEUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; SULFONAMIDES; URINARY TRACT INFECTIONS; URINE